Richard Beigi, MD, MSc

Professor of Reproductive Sciences



Dr. Beigi primarily performs clinical trials related to testing of various infectious disease related pharmaceutical products for the prevention and management of ID conditions in pregnant and lactating women. He is a member of the University of Pittsburgh’s Division of Reproductive Infectious Diseases and Immunology and an investigator in the Microbicides Trials Network.


Selected Publications

  • Beigi RH. The Importance of Studying Antimicrobials in Pregnancy. Seminars in
    Perinatology 2015;39:556-560.
  • Swamy GK, Beigi RH. Maternal Benefits of Immunization During Pregnancy. Vaccine 2015;33:6436-40.
  • Pillai VC, Han K, Beigi RH, Hankins GD, Clark S, Hebert MF, Easterling TR, Zajicek A, Ren Z, Caritis SN, Venkataramanan V. Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women. Br J Clin Pharmacol 2015;80:1042-50.
  • Beigi RH, Pillai VC, Venkataramanan R, Caritis SN. Oseltamivir for the Treatment of H1N1 Influenza During Pregnancy. Clin Pharmacol Ther 2015;98:403-5.
  • Beigi RH, Fortner KB, Munoz FM, Roberts J, Gordon JL, Han HH, Glenn G, Dormitzer PR, Gu XX, Read JS, Edwards K, Patel SM, Swamy GK. Maternal Immunization: Opportunities for Scientific Advancement. Clin Infect Dis 2014;59 Suppl 7:S408-14.
  • Beigi R, Venkataramanan R, Caritis SN. Oseltamivir for influenza in pregnancy.  Semin Perinatol 2014;38:503-7.
  • Moniz M, Beigi RH. Maternal Immunization: Clinical experiences, challenges and opportunities In vaccine acceptance. Hum Vaccin Immunother 2014;10:2562-70.
  • Beigi RH, Noguchi L, Parsons T, Macio I, Kunjara Na Ayudhya R, Chen J, Hendrix C, Masse B, Valentine M, Piper J, Watts H. Pharmacokinetics and placental transfer of single dose tenofovir 1% vaginal gel in term pregnancy. J Infect Dis 2011;204:1527-31.

For additional publications, see: blic/?sort=date&direction=ascending


Clinical Trials